Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2007-10-16
2007-10-16
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S400000, C424S422000, C424S423000, C424S427000, C424S430000, C424S445000, C424S447000, C530S300000, C530S324000, C530S326000, C530S327000, C514S002600, C514S012200, C514S013800, C514S014800
Reexamination Certificate
active
10325255
ABSTRACT:
Biomedical devices with antimicrobial coatings are provided. One or more surfaces of the device are coated with a cationic peptide, cationic proteins, or mixtures thereof to impart antimicrobial properties to the surface.
REFERENCES:
patent: 5472703 (1995-12-01), Vanderlaan et al.
patent: 6719929 (2004-04-01), Winterton et al.
patent: 2001/0045676 (2001-11-01), Winterton et al.
patent: 2004/0121939 (2004-06-01), Diana
patent: 2004/0126409 (2004-07-01), Willcox et al.
patent: 2004/0135967 (2004-07-01), Carney et al.
patent: 2005/0008676 (2005-01-01), Qiu et al.
patent: 0 990 924 (2000-04-01), None
patent: WO98/40091 (1998-09-01), None
patent: WO 01/56627 (2001-08-01), None
patent: WO 02/064183 (2002-08-01), None
patent: WO 02/064183 (2002-08-01), None
Aliwarga, Y. et al., “Antimicrobial peptides: a potential role in ocular therapy”, Clinical and Experimental Ophthalmology, Blackwell Science, AU, vol. 29, No. 3, Jun. 2001, pp. 157-160.
Boman, H.G. et al., “Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids”, Febs Letters, Elsevier Science Publishers, Amsterdam, NL, vol. 259, No. 1, Dec. 1989, pp. 103-106.
PCT International Search Report, dated Apr. 25, 2005, for PCT Int'l. Appln. No. PCT/US03/40675.
U.S. Appl. No. 09/516,636, filed Mar. 1, 2000, Johnson & Johnson.
Subbalakshmi et al., “Biological activities of C-terminal 15-residue synthetic fragment of melittin: deign of an analog with improved antibacterial activity” FEBS Letters, 448, pp. 62-66 (1999).
Juvvadi et al., “Synthetic Melittin, Its Entantio, Retro, and Retroenantio Isomers, and Selected Chimeric Analogs: Their Antibacterial, Hemolytic, and Lipid Bilayer Action” J. Am. Chem. Soc., vol. 118, pp. 8989-8997 (1996).
Mor et al., “The Vertebrate Peptide Antibiotics Dermaseptins Have Overlapping Structural Features but Target Specific Microorganisms” J. Biol. Chem, vol. 269, pp. 31635-31641 (1994).
Aliwarga et al., “Antimicrobial peptides: a potential role in ocular therapy” Clin. Exp. Ophthalmol., vol. 29, pp. 157-160 (2001).
Boman et al., “Antibacterial and antimalarial properties of peptieds that are cecropin-melittin hybrids” FEBS Letters, vol. 259, pp. 103-106 (1989).
Nos-Barbera et al., “Effect of Hybrid Peptides of Cecropin A and Melittin in an Experimental Model of Bacterial Keratitis” Cornea, vol. 259, pp. 101-106 (1996).
Wold, F., Posttranslation Protein Modifications: Perspectives and Prospects, pp. 1-12 in Posttranslational Covalent Modification of proteins, B. C. Johnson, Ed., Academic Press, New York (1983).
Seifter et al., “Analysis for Protein Modifications and Nonprotein Cofactors” (1990),Meth. Enzymol. 182, 626-646.
Rattan et al., “Protein Synthesis: Posttranslational Modifications and Aging”, (1992) Ann. N.Y. Acad. Sci. 663, 48-62.
Aliwarga Yulina
Cole Nerida
Diana Zanini
Hume Emma
Willcox Mark
Harding Karen
Johnson & Johnson Vision Care Inc.
Kosar Andrew D.
Tsang Cecilia J.
LandOfFree
Biomedical devices with antimicrobial coatings does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomedical devices with antimicrobial coatings, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomedical devices with antimicrobial coatings will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3822330